Last reviewed · How we verify
NCT04695457: PROCOPAD
Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps
trial in Covid19 in 74 participants. Completed in 16 November 2020.
16 November 2020
Quick facts
| Lead sponsor | Centre Hospitalier Annecy Genevois |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 74 |
| Start date | 15 July 2020 |
| Primary completion | 16 November 2020 |
| Estimated completion | 16 November 2020 |
| Sites | 1 location across France |
Conditions studied
- Covid19 — all drugs for Covid19 →
- Nursing Home — all drugs for Nursing Home →
Sponsor
Centre Hospitalier Annecy Genevois
Who can join
Eligibility, any sex, with Covid19 or Nursing Home. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Since the beginning of the COVID-19 outbreak in France, nursing homes (NH) have been heavily affected. In this study, the investigators want to evaluate the factors associated with the occurrence of COVID-19 epidemic clusters within the nursing homes in the French Alps
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04695457
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Centre Hospitalier Annecy Genevois trials
Trials by the same sponsor.
- NCT07248488 — Effect of an Intervention Combining the Use of Standardized Information and Sending an SMS Advice Message to Parents Cal · NA · not yet recruiting
- NCT06822127 — Simulation of Facial Soft Tissue in Orthognathic Surgery · NA · recruiting
- NCT06455553 — Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocyt · NA · completed
- NCT05817591 — Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or W · recruiting
- NCT05588414 — Performance Assessment of the Fluorescence Technique Alone in the Search for the Sentinel Node in Breast Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04695457 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Annecy Genevois
- Last refreshed: 5 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04695457.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing